![Catalina Lopez-Correa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catalina Lopez-Correa
Chief Tech/Sci/R&D Officer at Algae-C, Inc.
Profile
Catalina Lopez-Correa is currently the Director, Head-Genomics, Research & Development at Algae-C, Inc. Previously, she worked as the Chief Scientific Officer & VP-Sector Development at Genome British Columbia from 2016 to 2019 and as the Chief Scientific Officer & VP-Scientific at Génome Québec, Inc. She holds a doctorate degree from Katholieke Universiteit Leuven and Pontifical Bolivarian University.
Catalina Lopez-Correa active positions
Companies | Position | Start |
---|---|---|
Algae-C, Inc.
![]() Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Chief Tech/Sci/R&D Officer | - |
Former positions of Catalina Lopez-Correa
Companies | Position | End |
---|---|---|
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Chief Tech/Sci/R&D Officer | - |
Training of Catalina Lopez-Correa
Pontifical Bolivarian University | Doctorate Degree |
Katholieke Universiteit Leuven | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Commercial Services |
Algae-C, Inc.
![]() Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Catalina Lopez-Correa